Active Ingredient(s):Interferon Alfa-2b FDA Approved: * October 4, 1983 Pharm Company: *SCHERING Category:Hepatitis
Interferon alfa-2b is an antiviral or antineoplastic drug. It is a recombinant form of the protein Interferon alpha-2 that was originally sequenced and produced recombinantly in E. coli in the laboratory of Charles Weissmann at the University of Zurich, in 1980. It was developed at Biogen, and ultimately marketed by Schering-Plough under the trade name Intron-A. It was also produced in 1986 in recombinant human form, in the Center for G...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion